プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Nervana H.に依頼

United Arab Emirates

Senior Medical Affairs Leader | Pharma Consultant | GCC/MENA | Published Researcher | 17+ Years

プロフィール概要

Senior Medical Affairs professional with 17+ years of experience across the GCC and MENA region, with a strong track record at Pfizer, Johnson & Johnson, and Mundipharma. Expertise spans Medical Science Liaison leadership, KOL engagement, evidence generation, pre-launch and launch excellence, and cross-functional medical strategy. Published peer-reviewed researcher (JAC-AMR, paediatric antimicrobial resistance), with hands-on experience in antifungals, anti-infectives, cardiovascular, inflammation/immunology, and oncology. Proven ability to translate complex clinical data into impactful medical education and scientific exchange programs. Available for consulting in: medical writing, literature reviews, KOL mapping, MSL training, Medical Affairs strategy, launch readiness, and scientific advisory board facilitation across pharma and biotech clients.

専門分野

• ☆ Medical Sciences

サービス

• Writing
• Research
• Consulting
• Data & AI

Writing Medical Writing, Creative Writing, Translation

Research Market Research, Gap Analysis, Systematic Literature Review, Secondary Data Collection

Consulting Business Strategy Consulting, Go-to-Market Strategy Consulting, Healthcare Consulting, Scientific and Technical Consulting

Data & AI Data Insights

職務経験

Medical Science Liaison Hospital

Pfizer

- 現在

Medical Manager

Mundipharma

10月 2023 - 6月 2025

Area Medical Lead

Pfizer

5月 2021 - 10月 2023

Product Specialist

Johnson & Johnson - Medical Device Companies

1月 2009 - 8月 2012

学歴

PharmD (Doctor of Pharmacy)

Ain Shams University

9月 2002 - 6月 2007

認定資格

• AI Business

  NAS

  1月 2026 - 6月 2026

出版物

JOURNAL ARTICLE

Nervana Habashy, Wadha Alfouzan, Zainab Al-Balushi, Muna Al-Maslamani, Asmaa Al-Rashed, Salman Al-Sabah, Jameela Al-Salman, Mohamed Baguneid, Faryal Khamis, Ayman Kurdi, et al.(2021). Antimicrobial Management of Complicated Skin and Soft Tissue Infections in an Era of Emerging Multi-Drug Resistance: Perspectives from 5 Gulf Countries . Journal of Acute Care Surgery. 11. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 89--101. Korean Society of Acute Care Surgery

Nervana Habashy, Wadha Alfouzan, Zainab Al-Balushi, Muna Al-Maslamani, Asmaa Al-Rashed, Salman Al-Sabah, Jameela Al-Salman, Mohamed Baguneid, Faryal Khamis, Ayman Kurdi, et al.(2021). Antimicrobial Management of Complicated Skin and Soft Tissue Infections in an Era of Emerging Multi-Drug Resistance: Perspectives from 5 Gulf Countries . Journal of Acute Care Surgery. 11. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 89--101. Korean Society of Acute Care Surgery

Evaluation of the in vitro activity of ceftaroline, ceftazidime/avibactam and comparator antimicrobial agents against clinical isolates from paediatric patients in Kuwait: ATLAS data 2012–19 @article{2021, doi = {10.1093/jacamr/dlab159}, url = {https://doi.org/10.1093%2Fjacamr%2Fdlab159}, year = 2021, publisher = {Oxford University Press ({OUP})}, title = {{OUP} accepted manuscript}, journal = {{JAC}-Antimicrobial Resistance} } . JAC-Antimicrobial Resistance.

Evaluation of the in vitro activity of ceftaroline, ceftazidime/avibactam and comparator antimicrobial agents against clinical isolates from paediatric patients in Kuwait: ATLAS data 2012–19 @article{2021, doi = {10.1093/jacamr/dlab159}, url = {https://doi.org/10.1093%2Fjacamr%2Fdlab159}, year = 2021, publisher = {Oxford University Press ({OUP})}, title = {{OUP} accepted manuscript}, journal = {{JAC}-Antimicrobial Resistance} } . JAC-Antimicrobial Resistance.